{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:33Z","timestamp":1786988133208,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejphar.2020.173746","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T19:28:43Z","timestamp":1605814123000},"page":"173746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["An overview of viruses discovered over the last decades and drug development for the current pandemic"],"prefix":"10.1016","volume":"890","author":[{"given":"Agha Zeeshan","family":"Mirza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Shamshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal Abdulrhman","family":"Osra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turki M.","family":"Habeebullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz","family":"Morad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173746_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/v11020106","article-title":"Viruses teaching immunology: role of LCMV model and human viral infections in immunological discoveries","author":"Abdel-Hakeem","year":"2019","journal-title":"Viruses 11"},{"key":"10.1016\/j.ejphar.2020.173746_bib2","author":"Adem"},{"key":"10.1016\/j.ejphar.2020.173746_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5001\/omj.2019.36","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) in Oman: current situation and going forward","volume":"34","author":"Al Awaidy","year":"2019","journal-title":"Oman Med. J."},{"key":"10.1016\/j.ejphar.2020.173746_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.20506\/rst.19.2.1231","article-title":"Newcastle disease and other avian paramyxoviruses","volume":"19","author":"Alexander","year":"2000","journal-title":"Rev. Sci. Tech"},{"key":"10.1016\/j.ejphar.2020.173746_bib4","author":"Anderson"},{"key":"10.1016\/j.ejphar.2020.173746_bib5","author":"Arulanandam"},{"key":"10.1016\/j.ejphar.2020.173746_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2020.173746_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1573411013666170721112505","article-title":"Simultaneous determination of simvastatin with caffeine in bulk drug, formulation and their monitoring in mice plasma through HPLC-PDA technique","volume":"13","author":"Bkhaitan","year":"2017","journal-title":"Curr. Anal. Chem."},{"key":"10.1016\/j.ejphar.2020.173746_bib9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/CMR.00013-14","article-title":"Human astroviruses","volume":"27","author":"Bosch","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejphar.2020.173746_bib10","series-title":"Parainfluenza Virus Infections. MSD Manual","author":"Brenda","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173746_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"Orexin activation counteracts decreases in nonexercise activity thermogenesis NEAT caused by high fat diet","volume":"176","author":"Bunney","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2020.173746_bib12","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.3390\/v7102882","article-title":"Sequence and structure analysis of distantly-related viruses reveals extensive gene transfer between viruses and hosts and among viruses","volume":"7","author":"Caprari","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ejphar.2020.173746_bib13","series-title":"Features, evaluation and treatment coronavirus (COVID-19). StatPearls publishing, treasure island","author":"Cascella","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173746_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission\u00a0: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173746_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines\u00a0: 1987-2017 and beyond Innovation and trends in the development and approval of antiviral medicines\u00a0: 1987 \u2013 2017 and beyond","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2020.173746_bib16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","article-title":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173746_bib17","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.bmcl.2012.02.105","article-title":"Bioorganic & medicinal chemistry letters synthesis and antiviral activity of a series of 1 0 -substituted","volume":"22","author":"Cho","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173746_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4684-2706-6_2","article-title":"Reproduction of paramyxoviruses","author":"Choppin","year":"1975","journal-title":"Comprehensive Virology. Springer Link"},{"key":"10.1016\/j.ejphar.2020.173746_bib19","series-title":"Bench to Bedside Diagnostic Microbiology for the Clinicians","article-title":"Microbiological Diagnosis of Viral Diseases","author":"Choudhary","year":"2018"},{"key":"10.1016\/j.ejphar.2020.173746_bib20","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1073\/pnas.0701372104","article-title":"A previously unknown reovirus of bat origin is associated with an acute respiratory disease in humans","volume":"104","author":"Chua","year":"2007","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejphar.2020.173746_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejphar.2020.173746_bib22","series-title":"U.S. Natl. Libr. Med","author":"ClinicalTrialgov","year":"2020"},{"issue":"70","key":"10.1016\/j.ejphar.2020.173746_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/prd.12112","article-title":"Saliva and viral infections","volume":"2000","author":"Corstjens","year":"2016","journal-title":"Periodontol"},{"key":"10.1016\/j.ejphar.2020.173746_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejphar.2020.173746_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vetmic.2010.02.014","article-title":"Herpesvirus systematics","volume":"143","author":"Davison","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ejphar.2020.173746_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/CVI.00636-12","article-title":"Targeting the \u201ccytokine storm\u201d for therapeutic benefit. Clin","volume":"20","author":"Delia","year":"2013","journal-title":"Vaccine Immunol"},{"key":"10.1016\/j.ejphar.2020.173746_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0042-6822(64)90020-0","article-title":"Studies on Yucaipa: its classification as a member of the paramyxovirus group","volume":"22","author":"Dinter","year":"1964","journal-title":"Virology"},{"key":"10.1016\/j.ejphar.2020.173746_bib28","series-title":"The vaccine industry, in: Vaccines","author":"Douglas","year":"2013"},{"key":"10.1016\/j.ejphar.2020.173746_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.antiviral.2014.05.016","article-title":"The ecology of ticks and epidemiology of tick-borne viral diseases","volume":"108","author":"Estrada-Pe\u00f1a","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2020.173746_bib30","article-title":"Virus Taxonomy","author":"Fauquet","year":"2005"},{"key":"10.1016\/j.ejphar.2020.173746_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2016.09.001","article-title":"Molecular evolution of human Coronavirus genomes","volume":"25","author":"Forni","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejphar.2020.173746_bib32","first-page":"S110","article-title":"Exotic emerging viral diseases: progress and challenges. Nat. Med","volume":"10","author":"Geisbert","year":"2004"},{"key":"10.1016\/j.ejphar.2020.173746_bib33","series-title":"Medical Microbiology","article-title":"Control of Viral Infections and Diseases","author":"Goldenthal","year":"1996"},{"key":"10.1016\/j.ejphar.2020.173746_bib34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jiw431","article-title":"A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all chikungunya virus genotypes","volume":"214","author":"Goo","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2020.173746_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ajcp\/aqaa029","article-title":"Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19","volume":"153","author":"Guarner","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ejphar.2020.173746_bib36","first-page":"1","volume":"7","author":"Guo","year":"2020","journal-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 ( COVID-19 ) outbreak \u2013 an update on the status"},{"key":"10.1016\/j.ejphar.2020.173746_bib37","article-title":"Updated approaches against SARS-CoV-2","volume":"64","author":"Haiou","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2020.173746_bib38","series-title":"Vaccines for Biodefense and Emerging and Neglected Diseases","article-title":"Hantavirus","author":"Hammerbeck","year":"2009"},{"issue":"106055","key":"10.1016\/j.ejphar.2020.173746_bib39","article-title":"Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: insights from structures of protease and inhibitors","volume":"56","author":"He","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejphar.2020.173746_bib40","first-page":"242","volume":"16","author":"Henrickson","year":"2003","journal-title":"Parainfluenza Viruses"},{"key":"10.1016\/j.ejphar.2020.173746_bib41","author":"Holmes"},{"key":"10.1016\/j.ejphar.2020.173746_bib42","series-title":"Preparing for the Next Disease Outbreak","article-title":"The SARS epidemic and its aftermath IN China: a political perspective","author":"Huang","year":"2004"},{"key":"10.1016\/j.ejphar.2020.173746_bib43","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/bi036022q","article-title":"3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism","volume":"43","author":"Huang","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2020.173746_bib44","first-page":"1","article-title":"Overview of the first 6 Months of clinical trials for COVID-19 pharmacotherapy: the most studied drugs. Front","volume":"8","author":"Idda","year":"2020","journal-title":"Publ. Health"},{"key":"10.1016\/j.ejphar.2020.173746_bib45","first-page":"77","article-title":"Epidemiology of astrovirus infection in children. Korean J","volume":"55","author":"Jeong","year":"2012","journal-title":"An. Pediatr."},{"key":"10.1016\/j.ejphar.2020.173746_bib46","first-page":"145","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzyme Inhib","volume":"35","author":"Jo","year":"2020","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173746_bib47","series-title":"As the corona virus spreads, a drug that once raised the world's hopes is given a second shot. Statnews","author":"Joseph","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173746_bib48","series-title":"2020. Potential inhibitor of COVID-19 main protease ( M pro ) from several medicinal plant compounds by molecular docking study. Prepr. | NOT PEER-REVIEWED | posted 13","first-page":"1","author":"Khaerunnisa","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173746_bib49","author":"Khan"},{"key":"10.1016\/j.ejphar.2020.173746_bib50","first-page":"193","article-title":"Virus taxonomy: classification and nomenclature of viruses. Ninth rep","author":"King","year":"2012","journal-title":"Int. Comm. Taxon. Viruses"},{"key":"10.1016\/j.ejphar.2020.173746_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/187152611794407782","article-title":"Development of anti-viral agents using molecular modeling and virtual screening techniques","volume":"11","author":"Kirchmair","year":"2012","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.ejphar.2020.173746_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Kneller","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2020.173746_bib53","article-title":"Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19 Meehyun Ko","author":"Ko","year":"2020","journal-title":"bioRxiv Prepr"},{"issue":"8","key":"10.1016\/j.ejphar.2020.173746_bib54","doi-asserted-by":"crossref","first-page":"e43106","DOI":"10.1371\/journal.pone.0043106","article-title":"Isolation and characterization of three mammalian orthoreoviruses from European bats","volume":"7","author":"Kohl","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2020.173746_bib55","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1126\/science.1125998","article-title":"Clues to the virulence of H5N1 viruses in humans","volume":"311","author":"Krug","year":"2006","journal-title":"Science (80-. )"},{"key":"10.1016\/j.ejphar.2020.173746_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s13337-020-00571-5","article-title":"Structural, glycosylation and antigenic variation between 2019 novel Structural, glycosylation and antigenic variation between 2019 novel coronavirus ( 2019-nCoV ) and SARS coronavirus","volume":"31","author":"Kumar","year":"2020","journal-title":"VirusDisease"},{"key":"10.1016\/j.ejphar.2020.173746_bib57","series-title":"Paramyxoviridae. Fields Virol","author":"Lamb","year":"2012"},{"key":"10.1016\/j.ejphar.2020.173746_bib58","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.coi.2013.08.004","article-title":"Drug repurposing: a better approach for infectious disease drug discovery?","volume":"25","author":"Law","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejphar.2020.173746_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol"},{"key":"10.1016\/j.ejphar.2020.173746_bib60","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/156802606776287090","article-title":"Characterization and inhibition of SARS-coronavirus main protease","volume":"6","author":"Liang","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173746_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejps.2009.07.004","article-title":"Evaluation of the efficacy and safety of a statin\/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB\/c mice","volume":"38","author":"Liu","year":"2009","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2020.173746_bib62","article-title":"Treatments for COVID-19: Drugs Being Tested against the Coronavirus","author":"Live Science Staff","year":"2020","journal-title":"Livest. Sci."},{"key":"10.1016\/j.ejphar.2020.173746_bib63","author":"Lofy"},{"key":"10.1016\/j.ejphar.2020.173746_bib64","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","article-title":"Current progress in antiviral strategies","volume":"35","author":"Lou","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2020.173746_bib65","first-page":"1","article-title":"COVID-19 and diabetes","volume":"3","author":"Ma","year":"2020","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ejphar.2020.173746_bib66","series-title":"Fenner\u2019s Veterinary Virology","author":"Maclachlan","year":"2010"},{"key":"10.1016\/j.ejphar.2020.173746_bib67","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4155\/fmc.11.60","article-title":"Drug discovery and the use of computational approaches for infectious diseases","volume":"3","author":"Marh\u00f6fer","year":"2011","journal-title":"Future Med. Chem."},{"issue":"9","key":"10.1016\/j.ejphar.2020.173746_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203148","article-title":"Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors","volume":"13","author":"Mathew","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2020.173746_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.20506\/rst.19.1.1221","article-title":"Bat lyssavirus infections","volume":"19","author":"McCOLL","year":"2000","journal-title":"Rev. Sci. Tech"},{"key":"10.1016\/j.ejphar.2020.173746_bib70","article-title":"Dozens of COVID-19 vaccines are in development. Here are the ones to follow","author":"MCKEEVER","year":"2020","journal-title":"Natl. NOW Times"},{"key":"10.1016\/j.ejphar.2020.173746_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cll.2010.01.004","article-title":"Hantaviruses","volume":"30","author":"Mir","year":"2010","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.ejphar.2020.173746_bib72","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/15257770.2019.1615623","article-title":"Advancement in the development of heterocyclic nucleosides for the treatment of cancer - a review. Nucleosides","volume":"38","author":"Mirza","year":"2019","journal-title":"Nucleotides and Nucleic Acids"},{"key":"10.1016\/j.ejphar.2020.173746_bib73","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1073\/pnas.1601327113","article-title":"SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity","volume":"113","author":"Muramatsu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2020.173746_bib74","author":"Naik"},{"key":"10.1016\/j.ejphar.2020.173746_bib75","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.1073\/pnas.210382297","article-title":"From the Academy Emerging viral diseases","volume":"97","author":"Nichol","year":"2000","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejphar.2020.173746_bib76","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","article-title":"COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons","volume":"53","author":"Nile","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2020.173746_bib77","first-page":"S71","article-title":"New respiratory viruses of humans. Pediatr. Infect","author":"Osterhaus","year":"2008","journal-title":"Dis. J. 27"},{"key":"10.1016\/j.ejphar.2020.173746_bib78","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40121-020-00300-x","article-title":"Vaccines for SARS-CoV-2: lessons from other coronavirus strains","volume":"9","author":"Padron-Regalado","year":"2020","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ejphar.2020.173746_bib79","first-page":"1","article-title":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia","author":"Pan","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejphar.2020.173746_bib80","series-title":"Human parainfluenza viruses (HPIV) and other parainfluenza viruses. MedScape","author":"Parija","year":"2019"},{"key":"10.1016\/j.ejphar.2020.173746_bib81","series-title":"Devastating infectious diseases. Live sci","author":"Parry","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173746_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2008.10.009","article-title":"Noroviruses: a comprehensive review","volume":"44","author":"Patel","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ejphar.2020.173746_bib83","series-title":"Infectious Disease and Antimicrobial Agents","author":"Paul","year":"2010"},{"key":"10.1016\/j.ejphar.2020.173746_bib84","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera-A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejphar.2020.173746_bib85","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","article-title":"An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy","volume":"59","author":"Pillaiyar","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173746_bib86","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4269\/ajtmh.17-0866","article-title":"Perspective piece mosquito-borne human viral Diseases\u00a0: why Aedes aegypti\u00a0? Am","volume":"98","author":"Powell","year":"2018","journal-title":"J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejphar.2020.173746_bib87","first-page":"229","article-title":"Pulau virus; a new member of the Nelson Bay orthoreovirus species isolated from fruit bats in Malaysia. Arch","volume":"151","author":"Pritchard","year":"2006","journal-title":"Virol"},{"key":"10.1016\/j.ejphar.2020.173746_bib88","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1590\/S1413-86702007000100027","article-title":"H5N1 avian influenza virus: an overview","volume":"11","author":"Proen\u00e7a-M\u00f3dena","year":"2007","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2020.173746_bib89","series-title":"THERAPY ANTIVIRAL Antiviral Drugs for Viruses Other than Human Immunodeficiency Virus","author":"Razonable","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173746_bib90","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jcpa.2016.07.006","article-title":"Companion animals as a source of viruses for human beings and food production animals","volume":"155","author":"Reperant","year":"2016","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.ejphar.2020.173746_bib91","series-title":"The rapid journey of a deadly MERS outbreak [WWW Document]. KAIMRC Res. HIGHLIGHT","author":"RESEARCH HIGHLIGHT KAIMRC","year":"2019"},{"key":"10.1016\/j.ejphar.2020.173746_bib92","first-page":"195","article-title":"Recent understanding of the classification and life cycle of herpesviruses- A review","volume":"5","author":"Riaz","year":"2017","journal-title":"Sci. Lett."},{"key":"10.1016\/j.ejphar.2020.173746_bib93","article-title":"Everything you need to know about the COVID-19 therapy trials [WWW Document]","author":"Robinson","year":"2020","journal-title":"Pharm. J."},{"key":"10.1016\/j.ejphar.2020.173746_bib94","series-title":"Molecular Virology of Human Pathogenic Viruses","article-title":"Herpesviruses","author":"Ryu","year":"2017"},{"key":"10.1016\/j.ejphar.2020.173746_bib95","author":"Salim"},{"key":"10.1016\/j.ejphar.2020.173746_bib96","first-page":"26","article-title":"Emerging trends","volume":"6","author":"Saxena","year":"2010","journal-title":"Challenges and Prospects in Antiviral Therapeutics and Drug Development for Infectious Diseases"},{"key":"10.1016\/j.ejphar.2020.173746_bib97","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/1573409915666190827163327","article-title":"Characterization of the trypanosoma brucei pteridine reductase active- site using computational docking and virtual screening techniques","volume":"16","author":"Shamshad","year":"2020","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.ejphar.2020.173746_bib98","author":"Sheahan"},{"key":"10.1016\/j.ejphar.2020.173746_bib99","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1099\/jgv.0.000612","article-title":"Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family","volume":"97","author":"Smith","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejphar.2020.173746_bib100","series-title":"Infections and Infestations","first-page":"5","article-title":"Viral infections","author":"Sterling","year":"2016"},{"key":"10.1016\/j.ejphar.2020.173746_bib101","doi-asserted-by":"crossref","DOI":"10.1186\/cc6917","article-title":"Bench-to-bedside review: rare and common viral infections in the intensive care unit - linking pathophysiology to clinical presentation","volume":"12","author":"Stollenwerk","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2020.173746_bib102","series-title":"Minus-strand RNA viruses, in: in viruses and human disease","author":"Strauss","year":"2008"},{"key":"10.1016\/j.ejphar.2020.173746_bib103","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrmicro2950","article-title":"West Nile virus infection and immunity","volume":"11","author":"Suthar","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejphar.2020.173746_bib104","first-page":"389","article-title":"The role of microRNAs in respiratory viral infection","author":"Tahamtan","year":"2016","journal-title":"friend or foe"},{"issue":"4","key":"10.1016\/j.ejphar.2020.173746_bib105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants\u2020. J","volume":"10","author":"Tahir","year":"2020","journal-title":"Pharm. Anal"},{"key":"10.1016\/j.ejphar.2020.173746_bib106","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s007050050689","article-title":"Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus","volume":"145","author":"Takahashi","year":"2000","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejphar.2020.173746_bib107","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0042-6822(02)00049-1","article-title":"Distribution of TT virus (TTV), TTV-like minivirus, and related viruses in humans and nonhuman primates","volume":"306","author":"Thom","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.ejphar.2020.173746_bib108","series-title":"Severe acute respiratory syndrome ( SARS ) coronavirus\u00a0: application of monoclonal antibodies and development of an effective vaccine 117\u2013131","author":"Tsunetsugu-yokota","year":"2006"},{"key":"10.1016\/j.ejphar.2020.173746_bib110","doi-asserted-by":"crossref","first-page":"127377","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target. Bioorg","volume":"30","author":"Ullrich","year":"2020","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2020.173746_bib111","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(20)31787-6","article-title":"COVID-19 and readjusting clinical trials","volume":"396","author":"van Dorn","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejphar.2020.173746_bib112","article-title":"Electron microscopic evidence of Nariva virus structure","volume":"123","author":"Walder","year":"1971","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejphar.2020.173746_bib113","author":"Wang"},{"key":"10.1016\/j.ejphar.2020.173746_bib114","doi-asserted-by":"crossref","first-page":"569","DOI":"10.20506\/rst.33.2.2311","article-title":"Emerging zoonotic viral diseases","volume":"33","author":"Wang","year":"2014","journal-title":"OIE Rev. Sci. Tech"},{"key":"10.1016\/j.ejphar.2020.173746_bib115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-med-050715-105122","article-title":"Zika, chikungunya, and other emerging vector-borne viral diseases","volume":"69","author":"Weaver","year":"2018","journal-title":"Annu. Rev. ofMedicine"},{"key":"10.1016\/j.ejphar.2020.173746_bib116","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejphar.2020.173746_bib117","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1098\/rstb.2011.0354","article-title":"Human viruses: discovery and emeraence","volume":"367","author":"Woolhouse","year":"2012","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2020.173746_bib118","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs bycomputational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2020.173746_bib119","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejphar.2020.173746_bib120","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume":"41","author":"Yanping","year":"2020","journal-title":"Zhonghua Liuxingbingxue Zazhi"},{"key":"10.1016\/j.ejphar.2020.173746_bib121","author":"Yazdany"},{"key":"10.1016\/j.ejphar.2020.173746_bib122","first-page":"607","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm\u2019\u2019 in COVID-19.\u2019 J","volume":"80","author":"Ye","year":"2020","journal-title":"Infect"},{"key":"10.1016\/j.ejphar.2020.173746_bib123","series-title":"Overview of arbovirus, arenavirus, and filovirus infections","author":"Yuill","year":"2018"},{"key":"10.1016\/j.ejphar.2020.173746_bib124","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science (80-. )"},{"key":"10.1016\/j.ejphar.2020.173746_bib125","series-title":"On the classification of lyssaviruses. J vet sci med 5","author":"Zhu","year":"2016"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:46:14Z","timestamp":1757976374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920308384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":124,"alternative-id":["S0014299920308384"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173746","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of viruses discovered over the last decades and drug development for the current pandemic","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173746"}}